SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

SELLAS Life Sciences Group, Inc. is a clinical stage biopharmaceutical company, which engages in the development and commercialization of immunotherapeutic for cancer indications. Its product pipeline includes galinpepimut-S. The company was founded by Angelos M. Stergiou on April 3, 2006 and is headquartered in New York, NY.

SELLAS Life Sciences Group Inc

Speculation around a potential buyoutfueled by the CEOs anniversary message and the companys planned ASH presenceis competing with anticipation of a final analysis of SELLASs REGAL Phase 3 trial, last reported at 78 of 80 required events. Some traders read the prolonged trial and managements upbeat tone as encouraging, while others stress that no acquisition, event threshold, or trial result has been confirmed and that the recent price move may be trading without fresh news.

Sea Ltd. is an internet and mobile platform company, which engages in the provision of online gaming services. It operates through the following segments: Digital Entertainment, E-Commerce, and Digital Financial Services. The Digital Entertainment segment offers and develops mobile and PC online games. The E-Commerce segment manages a third-party marketplace through the Shopee mobile app and websites that connect buyers and sellers. The Digital Financial Services segment includes a variety of payment services and loans to individuals and businesses through SeaMoney. Sea was founded by Xiao Dong Li, Gang Ye, and Jing Ye Chen on May 8, 2009 and is headquartered in Singapore.

Sea Ltd - ADR

Seas plan to pursue a public listing for its Monee financial-services arm is fueling debate as shares sell off. Some traders see the separation and uncertain timeline as an overhang that could leave Sea with less valuable businesses, while others argue shareholders could benefit from receiving Monee shares or from the business being valued separately.

Netflix, Inc. engages in providing entertainment services. It also offers activities for leisure time, entertainment video, video gaming, and other sources of entertainment. It operates through the United States and International geographic segments. The company was founded by Marc Randolph and Wilmot Reed Hastings on August 29, 1997 and is headquartered in Los Gatos, CA.

Netflix Inc.

Netflix Inc

Netflixs Q3 earnings and outlook dominate discussion, with traders focused on subscriber engagement and growth, ad revenue, and the effect of recent layoffs and content-leadership changes. Views are sharply divided: some see low expectations and a chance for a rebound, while others fear further weakness, citing the stocks decline and its recent post-earnings performance.

BioCryst Pharmaceuticals, Inc. is a biotechnology company. It engages in the provision of structure-guided drug design with the goal of developing oral small-molecule and protein therapeutics to target difficult-to-treat rare diseases. The company was founded by William M. Spencer III, Charles E. Bugg, and John A. Montgomery in 1986 and is headquartered in Durham, NC.

Biocryst Pharmaceuticals Inc.

BCRX is drawing attention for its persistent share-price weakness despite Orladeyo growth, with many traders criticizing management and the Astria acquisition while others argue the business is undervalued. The debate also focuses on upcoming product updates and Navenibart and Netherton data: bulls see potential catalysts, while skeptics question execution and face of HAE competition.

Myriad Genetics, Inc. is a molecular diagnostics and precision medicine company committed to advancing health and well-being for all. It develops and commercializes molecular tests that help patients and providers uncover genetic insights. The company was founded by Walter A. Gilbert, Mark H. Skolnick, and Peter D. Meldrum in May 1991 and is headquartered in Salt Lake City, UT.

Myriad Genetics, Inc.

Myriads agreement to sell its prenatal testing business to Labcorp has driven a sharp rally, with traders focused on the cash proceeds and potential balance-sheet and strategic benefits. The reaction is divided: some see a positive reset, while skeptics worry the divestiture removes a meaningful revenue business and leaves weaker operations and debt concerns.

GE Aerospace is an American aircraft company, which engages in the provision of jet and turboprop engines, as well as integrated systems for commercial, military, business, and general aviation aircraft. The firm's portfolio of brands includes Avio Aero, Unison, GE Additive, and Dowty Propellers. It operates through the following segments: Commercial Engines and Services, Defense and Propulsion Technologies, and Corporate and Other. The Commercial Engines and Services segment is involved in the design, development, manufacturing, and servicing of jet engines for commercial airframes, as well as business aviation and aeroderivative applications. The Defense and Propulsion Technologies segment offers defense engines and critical aircraft systems. The Corporate and Other segment relates to corporate functions and operations costs. The company was founded by Thomas Alva Edison in 1878 and is headquartered in Evendale, OH.

GE Aerospace

GE is selling off despite a quarterly earnings beat and higher full-year guidance, as traders focus on rising costs, weaker cash conversion, lower-margin sales and a loss in its insurance business; some also worry that engines are accumulating at Boeing ahead of aircraft deliveries. The reaction has frustrated bullish traders who see strong demand and orders, while others view the selloff as evidence that profitability and execution matter more than the headline beat.

Sarepta Therapeutics, Inc. is a commercial-stage biopharmaceutical company, which is engaged in the discovery and development of therapeutics for the treatment of rare diseases. The company was founded on July 22, 1980 and is headquartered in Cambridge, MA.

Sarepta Therapeutics Inc

Sarepta is drawing attention as shares rebound while traders look ahead to clinical readouts for its DM1 and FSHD siRNA programs, alongside discussion of Arrowhead data as a possible validation of the technology. Bulls see the pipeline as a potential growth driver, while skeptics say early or preclinical results still need to translate into meaningful patient benefit and question the stocks weak price action.

SPDR Series Trust - State Street SPDR S&P Biotech ETF

SPDR S&P Biotech ETF

A broad biotech-sector rebound is driving attention, with traders describing XBI as breaking out after a sharp pullback and citing renewed buying and possible rotation into biotech. Bulls see a recovery taking hold, while skeptics warn the bounce could fade amid rate and other macro headwinds.

Rapport Therapeutics, Inc. engages in the discovery and development of transformational small molecule medicines for patients suffering from central nervous system disorders. It develops the RAP (receptor associated proteins) technology platform. The company was founded by Steven M. Paul and David Bredt in February 2022 and is headquartered in Boston, MA.

Rapport Therapeutics Inc.

Rapport Therapeutics Inc

Rapports Phase 2 trial of RAP-219 in bipolar mania met its primary and secondary endpoints, driving a sharp burst of bullish attention. Traders are divided over whether the modest placebo-adjusted improvement and safety and discontinuation concerns make the result less compelling, with some viewing it as proof of concept and others expecting the rally to fade.

Trump Media & Technology Group Corp. engages in operating social media and in the technology business. Its brands include TRUTH Social, TMTG+, and TMTG News. It operates through the Media and Truth.Fi segments. The Media segment includes products and services such as advertisement through the Truth Social platform. The Truth.Fi segment relates to customized exchange-traded funds or exchange-traded products invested in America First principles, and bitcoin and similar cryptocurrencies or crypto-related securities. The company was founded on March 28, 2024 and is headquartered in Sarasota, FL.

Trump Media & Technology Group Corp.

DJTs slide to record lows is being discussed alongside expectations of Republican losses in the midterms and declining confidence in Trump, with many traders blaming the stocks political association and questioning the companys business value. The conversation is predominantly bearish, though some traders see a possible short-term bounce.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

These Precious Metals ETFs Beat The S&P 500 Over The Past Year — Can The Rally Survive The Iran Whiplash?

Equity

The World Bank projects that its precious metals price index will rise by 42% in 2026, but decline by 8% in 2027. 

Fading Haven Demand Hits Dollar: ETFs to Consider Now

As risk appetite returns, the greenback is losing its safe-haven shine. Let's take a look at ETFs that could benefit from a weakening USD.

Dollar at a 4-Year Low? ETFs That You Could Play

The U.S. dollar sinks to a four-year low as rate-cut bets and policy uncertainty rise. These ETFs offer investors a way to hedge, diversify and capitalize on opportunities

ETFs That Investors May Consider Amid a Dollar Drag

As the dollar weakens and rate-cut bets rise, these ETFs offer investors a way to hedge, diversify and capitalize on opportunities.

What's Driving Precious Metal ETFs Rally in 2025?

Precious metal ETFs like GLTR, PPLT, GLD and SLV shine in 2025, lifted by safe-haven demand, strong industrial consumption and tight supply.


The GLTR ETF May Be a ‘Golden’ Opportunity Now

I use Barchart’s screening functions to find stocks with high technical “buy” signals and strong momentum, but this method struggles in the current market. Despite declines in the S&amp;P 500 Index ($SPX) and Nasdaq-100 Index ($IUXX) , precious metals like gold and silver are performing well.  This makes the Aberdeen...

Precious Metals in Q1 2025- Where are they Heading in Q2?

The precious metals sector led the commodities asset class higher in Q1 2025, with over 18% gains in gold and silver. Platinum and palladium prices moved to the upside, and rhodium posted an over 20% gain in the quarter that ended on March 31, 2025.

Precious Metals in Q4 and 2024- Where are they Heading in 2025?

The precious metals sector declined in Q4 but moved to the upside in 2024. While gold and silver posted over 20% gains for the year, platinum and palladium futures were down over 10%. Gold was the only precious metal moving higher in Q4, as the price rose to a new record peak during the year’s final quarter.

Abrdn Precious Metals Basket ETF Trust - Units of fractional undivided beneficial interest

Neutral Sentiment

<ul class="summary-bullets"><li>Over the past year, top precious metals ETFs have delivered far superior returns than the benchmark S&amp;P 500 index.&nbsp;</li><li>The iShares Silver Trust (SLV) surged more than 64% over the last year, and the SPDR Gold Shares (GLD) advanced nearly 24%, while the SPDR S&amp;P 500 ETF Trust (SPY) posted about 22% gains.</li><li>The World Bank expects gold prices to rise by about 37% in 2026 before declining by 9% in 2027, and expects silver prices to increase by 76% in 2026 before falling by about 7% in 2027.</li></ul>The precious metals trade has quietly outpaced the broader market over the past year, with silver leading the charge and diversified metals funds also delivering stronger returns than the benchmark S&amp;P 500.While silver and gold have retreated from their highs earlier this year, the lingering U.S.-Iran tensions and continued central bank purchases may continue to underpin demand for safe-haven assets.Despite the recent pullback, the World Bank <a class="st-link-external" target="_blank" rel="noopener noreferrer nofollow" href="https://blogs.worldbank.org/en/opendata/precious-metals-retreat-from-record-highs">projects</a> that its precious metals price index will rise by 42% in 2026, but decline by 8% in 2027.<h2 class="st-heading-2">Precious Metals ETFs Outperform S&amp;P 500</h2>Over the past year, the top precious metals exchange-traded funds (ETFs) have delivered far superior returns than the benchmark S&amp;P 500 index.The <a href="https://stocktwits.com/symbol/slv">iShares Silver Trust (SLV)</a> surged more than 64% over the last year, while the <a href="https://stocktwits.com/symbol/gltr">abrdn Physical Precious Metals Basket Shares ETF (GLTR)</a>, which comprises physical gold, silver, platinum and palladium, has returned about 34% in the same period.The <a href="https://stocktwits.com/symbol/gld">SPDR Gold Shares (GLD)</a>, which tracks the spot price of gold, has advanced nearly 24%, while the <a href="https://stocktwits.com/symbol/dbp">Invesco DB Precious Metals Fund (DBP)</a> gained nearly 29%.By comparison, the <a href="https://stocktwits.com/symbol/spy">SPDR S&amp;P 500 ETF Trust (SPY)</a>, which tracks the S&amp;P 500 index, posted about 22% gains.<figure class="image"><img src="https://news.stocktwits-cdn.com/koyfin_20260710_090817564_png_f16b5ef8f6.webp" alt="koyfin_20260710_090817564.png" width="2400" height="1500"></figure><h2 class="st-heading-2">Outlook Is Shiny For Precious Metals Despite Recent Declines</h2>However, precious metal prices declined in the second quarter of 2026. As per the World Bank, by June, gold was about 15% below its February peak, while silver and platinum were about 25% below their January record highs.<figure class="image"><img src="https://news.stocktwits-cdn.com/koyfin_20260710_094144169_png_9e3d7e87ed.webp" alt="koyfin_20260710_094144169.png" width="2400" height="1500"></figure>However, the apex bank still believes the metals have room to run through the end of the year. “Gold is expected to remain supported by safe-haven demand and continued central bank purchases. Silver and platinum prices should remain firm, underpinned by industrial demand and constrained supply,” the World Bank said in late June.“Risks are tilted to the upside, particularly from renewed geopolitical tensions, policy uncertainty, and financial market volatility,” it added.The outlook is underpinned by renewed tensions between the U.S. and Iran. Conflict increased after Iran attacked three commercial ships passing through the Strait of Hormuz earlier this week, following which the U.S. initiated strikes against the Middle Eastern country and revoked a previous license that had lifted sanctions on Iran's oil.Meanwhile, Trump told reporters on Thursday that he is unsure whether the U.S. and Iran are heading back into a full-scale war, after he mentioned previously that the U.S. may not be interested in negotiating a deal with Iran any longer. The president had also said that the ceasefire between the two countries was “over.”Meanwhile, central bank buying of gold is also expected to continue, bolstering prices.<h2 class="st-heading-2">Precious Metals Targets</h2>The World Bank expects gold prices to rise by about 37% in 2026 before declining by 9% in 2027. Meanwhile, it expects silver prices to increase by 76% in 2026, then fall by about 7% in 2027, and platinum prices to average about 53% higher in 2026 before declining by about 13% in 2027.<figure class="image"><img src="https://news.stocktwits-cdn.com/precious_metals_forecast_png_9e1b74ab98.webp" alt="precious-metals-forecast.png" width="1220" height="950"><figcaption>Source: World Bank</figcaption></figure>Meanwhile, JPMorgan reportedly expects demand for gold from key sectors to be more muted than expected. According to a recent Reuters <a class="st-link-external" target="_blank" rel="noopener noreferrer nofollow" href="https://www.reuters.com/business/jp-morgan-says-weaker-demand-may-cap-gold-gains-near-term-sees-rebound-late-2026-2026-07-03/">report</a>, the bank sees gold prices at $4,500 per ounce by the fourth quarter, an increase of about 9% from the current level of $4,123.01.The bank maintained its positive long-term outlook for gold, saying the metal could climb further in 2027 as central bank buying and physical demand remain supported by structural accumulation trends.For silver, it expects prices to average between $60 and $65 per ounce over the forecast period, driven by a normalization in the gold-to-silver ratio and easing concerns around the tight physical market conditions seen last year.Platinum is projected to reach an average of about $1,800 per ounce by the end of 2026 and rise to roughly $1,950 by the end of 2027, while palladium is projected to trade around $1,350 per ounce by the end of 2026 before averaging close to $1,300 in 2027.For updates and corrections, email newsroom[at]stocktwits[dot]com.

Gold and silver bars of various sizes lie in a safe on a table at the precious metals dealer Pro Aurum

Invesco DB Precious Metals Fund

SPDR Gold Shares ETF

abrdn ETF - abrdn Physical Precious Metals Basket Shares ETF

iShares Silver Trust

Double beat (rev + EPS)

Revenue beat, EPS miss

EPS beat, revenue miss

Double miss

SpaceX ($SPCX) reports earnings after the close today. What do you expect?

Stocktwits

SpaceX

) reports earnings after the close today. What do you expect?

Feed

News

Sentiment

Fundamentals

Info

GLTR abrdn ETF - abrdn Physical Precious Metals Basket Shares ETF

Fundamentals

Latest GLTR News